The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of molecular subtype, proliferation, and immune genes with efficacy of carboplatin versus gemcitabine addition to taxane-based, anthracycline-free neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Results of the randomized WSG ADAPT-TN trial.
 
Oleg Gluz
Travel, Accommodations, Expenses - Celgene; Teva
 
Cornelia Liedtke
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Gedeon Richter; Genomic Health; GlaxoSmithKline; Novartis; Pierre Fabre; Roche; Teva
Consulting or Advisory Role - Genomic Health; Novartis; Pierre Fabre; Roche; Teva
Speakers' Bureau - Genomic Health
Research Funding - Boehringer Ingelheim; Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; PharmaMar; Roche; Teva
 
Aleix Prat
Consulting or Advisory Role - NanoString Technologies
 
Matthias Christgen
No Relationships to Disclose
 
Daniel Gebauer
No Relationships to Disclose
 
Ronald E. Kates
No Relationships to Disclose
 
Eva-Maria Grischke
No Relationships to Disclose
 
Helmut Forstbauer
No Relationships to Disclose
 
Michael Wilhelm Braun
No Relationships to Disclose
 
Mathias Warm
Employment - Celgene (I)
 
John Hackmann
No Relationships to Disclose
 
Christoph Uleer
No Relationships to Disclose
 
Bahriye Aktas
No Relationships to Disclose
 
Claudia Schumacher
No Relationships to Disclose
 
Sherko Kummel
No Relationships to Disclose
 
Rachel Wuerstlein
Honoraria - Celgene; Genomic Health; NanoString Technologies; Pfizer; Roche
 
Enrico Pelz
No Relationships to Disclose
 
Ulrike Nitz
Consulting or Advisory Role - Genomic Health; Roche
 
Hans Heinrich Kreipe
Consulting or Advisory Role - AstraZeneca; Roche
 
Nadia Harbeck
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Hexal; Novartis; Pfizer; Roche/Genentech; Sandoz
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)